Acetazolamide Prices — US Pharmacy Cost vs Canada — Save Up to 68% in the US

At the US pharmacies in our data, the lowest listed discount-card price for Acetazolamide Er is around $27.81. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.

Yes — Cost Plus Drugs lists Acetazolamide Er at roughly $0.190 per unit, a published price with no membership card or coupon involved. See the three-price comparison above for how that stacks up against discount-card pharmacies.

Canadian pharmacy listings in our data show Acetazolamide Er priced from about $0.150 per tablet (converted to USD), before shipping. Pack size and pharmacy both affect the final total — see the Canada pricing table for specifics.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. In this case, our data shows the US price is actually the lower of the two once a program like Cost Plus Drugs is factored in — the assumption that Canada is always cheaper doesn't hold for every drug.

Your insurance copay for Acetazolamide ER will vary based on your specific plan's formulary and the dose prescribed. It's a good practice to ask your pharmacist to compare your insurance copay against the price available through a prescription discount program, as the latter may sometimes offer lower out-of-pocket costs.

Acetazolamide ER is the generic extended-release version of the drug. Its former brand-name counterpart was Diamox Sequels, which has been discontinued by the manufacturer due to the availability of generic alternatives. Generic Acetazolamide ER is produced by several manufacturers, including Alembic, Heritage, and Taro.

Acetazolamide ER is a generic prescription drug primarily used to treat glaucoma. This condition involves elevated pressure inside the eye due to excess fluid, which can damage the optic nerve and lead to vision loss. As a carbonic anhydrase inhibitor, the medication reduces the production of this intraocular fluid, thereby lowering pressure. It is typically taken once or twice daily as an an extended-release tablet, with dosage determined by the severity of the condition.